Epidemiology of Barrett's Esophagus: A Population Based Study
NCT ID: NCT01286155
Last Updated: 2013-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
534 participants
OBSERVATIONAL
2010-01-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To develop a population based clinical risk factor prediction model for the diagnosis of BE and identify novel risk factors for BE which would make population based screening more efficient. This will be an important first step in identifying the target population for BE screening, another crucial component of making screening feasible and efficient
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Detection of Barrett's Esophagus
NCT00081354
Enhancing Screening Practices for BE
NCT07335445
Barrett's Esophagus Patient Registry
NCT01776346
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
NCT06693622
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
NCT06523374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
with gastroesophageal reflux disease(GERD)
Subjects with gastroesophageal reflux disease (GERD)
No interventions assigned to this group
Non-GERD
Subjects with no history of gastroesophageal reflux disease (GERD)
No interventions assigned to this group
Barrett's esophagus
Subjects with confirmed barrett's esophagus in Olmsted county
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Control # 1 : Olmsted county residents \> 18 years old that responded to a recent community based survey and reported gastroesophageal reflux (GER) symptoms at least once a week and without a known diagnosis of BE.
3. Control # 2 : Olmsted county residents \> 18 years old that responded to a recent community based survey that did not report any GER symptoms and without a known diagnosis of BE.
Exclusion Criteria
1. Have died prior to the start of this study;
2. Refuse to participate;
2. Controls: respondents to the "constipation survey" who
1. Are known to have BE;
2. Have died prior to the start of this study;
3. Refuse to participate; -
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American College of Gastroenterology
OTHER
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prasad G. Iyer
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-002718
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.